ReviewJournal of neurology2006
News on the genetics, epidemiology, medical care and translational research of Schwannomas.
Review in Journal of neurology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 59 citations in OpenAlex.
- Surgical management of peripheral nerve sheath tumours: a 10-year retrospective UK study.Brain & spine · 2026Article
- A Rare Cause of Dysphagia: Hypopharyngeal Schwannoma.Journal of maxillofacial and oral surgery · 2025Article
- Presumed Pediatric Isolated Oculomotor Nerve Schwannoma - A Case Report.International medical case reports journal · 2025Article
- Surgical treatment of rare peripheral nerve lesions: long-term outcomes and quality of life.Frontiers in oncology · 2024Article
- Axillary schwannoma mimicking lymph node metastasis-associated breast cancer: a case report.Surgical case reports · 2022Article
- A rare case of penile schwannomatosis presenting with painful nocturnal penile tumescence.Basic and clinical andrology · 2022Article
- Giant sacral schwannoma excised under intraoperative neuromonitoring in an elderly patient: case report.Journal of surgical case reports · 2021Article
- A clinicopathological study of peripheral schwannomas.Medicine and pharmacy reports · 2021Article
- Primary recurrent orbital schwannoma treated with surgical excision and Mitomycin-C.American journal of ophthalmology case reports · 2020Article
- Oculomotor schwannoma causing a progressive complete third-nerve palsy.BMJ case reports · 2019Article
- Why are olfactory ensheathing cell tumors so rare?Cancer cell international · 2019Review
- Schwannoma of the vagina - a common tumor but a rare location: A case report.Molecular and clinical oncology · 2017Article
- Merlin, the NF2 gene product.Pathology oncology research : POR · 2013Review
- Recurrent orbital schwannomas: clinical course and histopathologic correlation.BMC ophthalmology · 2012Article
- Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.Croatian medical journal · 2012Article
- Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.Neuro-oncology · 2011Article
- Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.Nature reviews. Neurology · 2011Review
- Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.Brain pathology (Zurich, Switzerland) · 2009Article
- The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent years have seen substantial news and updates in the genetics and diagnosis of schwannomas, even a new hereditary disease with schwannomas; Schwannomatosis has been defined. These developments have consequently led to better evaluation of the incidence of schwannomas. Although there has also been progress in the treatment of schwannomas especially in the field of radiation therapy, hereditary diseases with multiple tumours still represent a therapeutic dilemma. NF2 in particular still causes major morbidity and mortality owing to the neurological deficit of multiple tumour disease and deafness caused by vestibular nerve involvement. Thus there has been great enthusiasm about disease models in the hope that translational research will give rise to new therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.